Frontotemporal dementia (FTD) encompasses a group of neurodegenerative disorders characterized by progressive deficits in behavior, language, and executive function. The temporal cortex—particularly the anterior and lateral regions—is prominently affected in multiple FTD subtypes, with distinct patterns of neuronal loss, protein pathology, and clinical manifestations.
Temporal cortex involvement in FTD provides insight into disease mechanisms and distinguishes FTD from Alzheimer's disease, which typically shows later temporal lobe involvement (mesial temporal structures). Understanding temporal cortex pathology is essential for accurate diagnosis, prognostication, and therapeutic development.
The semantic variant of PPA shows the most selective temporal cortex involvement:
Anatomical distribution:
- Anterior temporal lobe: Most severely affected, often asymmetric (left > right)
- Bottom of superior temporal sulcus: Early involvement
- Temporal pole: Progressive atrophy
- Amygdala and hippocampus: Variable involvement
Pathology:
- TDP-43 Type C inclusions (neuronal cytoplasmic and intranuclear)
- Spherical tau-negative inclusions
- Relative preservation of posterior temporal and parietal regions
- "Knife-edge" appearance of atrophic cortex
Clinical features:
- Loss of word meaning (semantic knowledge)
- Object recognition deficits
- Surface dyslexia (reading errors)
- Spared speech production
Anatomical distribution:
- Posterior superior temporal gyrus: Left hemisphere predominant
- Angular gyrus: Language-related network disruption
- Posterior temporal-parietal junction: Variable
Pathology:
- Often AD-type pathology (tau)
- May have TDP-43 in some cases
- Less selective than svPPA
Clinical features:
- Anomia (word-finding difficulty)
- Phonological errors
- Sentence repetition impairment
- Spared comprehension (initially)
Anatomical distribution:
- Anterior temporal lobes: Often bilateral
- Orbitofrontal cortex: Early involvement
- Anterior cingulate: Variable
- Insula: Variable
Pathology:
- TDP-43 Type B (most common)
- Less commonly tau (Pick disease, CBD, PSP)
- Heterogeneous subtypes
Clinical features:
- Disinhibition and inappropriate behavior
- Apathy and loss of initiative
- Loss of empathy
- Dietary changes (hyperphagia)
Tau inclusions in temporal cortex:
| Pathology Type |
Protein |
FTD Subtype |
Distribution |
| Pick bodies |
3R tau |
Pick disease |
Frontal and temporal |
| CBD tau |
4R tau |
CBD |
Posterior temporal |
| PSP tau |
4R tau |
PSP |
Brainstem, basal ganglia |
Neurofibrillary tangles:
- Prefrontal and anterior temporal predominance
- Correlation with neuronal loss
- Progressive spread pattern
Neuronal loss:
- 30-60% reduction in severely affected regions
- Layer-specific vulnerability (layers II, III)
- Associated with gliosis
TDP-43 inclusions in temporal cortex:
| Type |
Characteristics |
FTD Subtype |
| Type A |
Neuronal intranuclear inclusions, dystrophic neurites |
bvFTD, CBS |
| Type B |
Dense cytoplasmic inclusions, no intranuclear |
bvFTD, ALS-FTD |
| Type C |
slender neurites, no inclusions |
svPPA |
| Type D |
VCP mutations, intranuclear |
IBMPFD |
Neuronal inclusions:
- Cytoplasmic and nuclear TDP-43
- Ubiquitin-positive
- Correlate with neuronal loss
- Less common than tau/TDP-43
- FUS-positive inclusions
- Usually in young-onset FTD
- Associated with ALS
| Protein |
FTD Subtype |
Mechanism |
| Tau (3R/4R) |
Pick disease, CBD, PSP |
Alternative splicing, mutations |
| TDP-43 |
svPPA, bvFTD, ALS-FTD |
Mitochondrial dysfunction, stress |
| FUS |
ALS-FTD, ETF |
RNA processing disruption |
| VCP |
IBMPFD |
Autophagy, ubiquitin processing |
Dendritic spine loss:
- Correlation with cognitive decline
- Early manifestation (pre-neuronal loss)
- Targets excitatory synapses
Neurotransmitter deficits:
- Glutamate: Excitotoxicity
- Acetylcholine: Basal forebrain involvement
- Serotonin: Raphe nuclei involvement
Network disruption:
- Default mode network impairment
- Salience network alterations
- Language network disruption
Anomia:
- Word-finding difficulties
- Tip-of-the-tongue phenomenon
- Circumlocution strategies
- Progresses to complete loss
Comprehension deficits:
- Semantic memory loss
- Impaired word comprehension
- Object recognition failure
- Reading comprehension decline
Repetition deficits:
- Phonological errors
- Sentence repetition impairment
- Agraphia (writing difficulty)
Anterior temporal involvement:
- Loss of empathy
- Social cognition deficits
- Theory of mind impairment
Orbitofrontal involvement:
- Disinhibition
- Inappropriate social behavior
- Loss of manners
Dietary changes:
- Hyperphagia (especially sweet foods)
- Food preference changes
- Weight gain
| Target |
Approach |
Status |
| Serotonergic |
SSRIs |
May reduce disinhibition |
| Glutamatergic |
Memantine |
Mixed results |
| Cholinergic |
AChE inhibitors |
Limited benefit |
| Dopaminergic |
Stimulants |
For apathy |
Anti-aggregation therapies:
- Tau aggregation inhibitors
- TDP-43 targeting strategies
RNA-based approaches:
- Antisense oligonucleotides
- RNA splicing modifiers
Neuroprotection:
- Neurotrophic factors
- Antioxidants
- Anti-inflammatory approaches
flowchart TD
A["Anterior Temporal Cortex"] --> B["Semantic Memory"]
B --> C["Word Meaning<br/>Object Recognition"]
A --> D["Social Cognition"]
D --> E["Empathy<br/>Theory of Mind"]
A --> F["Language Network"]
F --> G["Word Retrieval<br/>Comprehension"]
style A fill:#e1f5fe,stroke:#333
style C fill:#ffcdd2,stroke:#333
style E fill:#ffcdd2,stroke:#333